Quest Diagnostics
DGX
#1113
Rank
โ‚น2.067 T
Marketcap
โ‚น18,678
Share price
0.72%
Change (1 day)
28.01%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2026 (TTM): โ‚น819.41

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น877.39. In 2025 the company made an earnings per share (EPS) of โ‚น848.68 an increase over its 2024 EPS that were of โ‚น744.39.

EPS history for Quest Diagnostics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น819.41-3.45%
2025โ‚น848.6814.01%
2024โ‚น744.392.5%
2023โ‚น726.21-5.83%
2022โ‚น771.18-49.21%
2021โ‚น1,51849.72%
2020โ‚น1,01466.67%
2019โ‚น608.5218%
2018โ‚น515.72-4.26%
2017โ‚น538.6823.19%
2016โ‚น437.26-7.11%
2015โ‚น470.7528.46%
2014โ‚น366.45-31.61%
2013โ‚น535.8160.46%
2012โ‚น333.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น1,087 23.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น68.10-107.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น59.32-106.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น197.11-77.53%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น20.09-102.29%๐Ÿ‡บ๐Ÿ‡ธ USA